ArticleChemistry & biodiversity2026
Integrated Morphological, Molecular, and Chemical Characterization of the Macrofungus Pholiota Gallica With Phylogenetic Analysis and in Silico Antioxidant and Anti-Inflammatory Evaluation.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pholiota gallica is a rarely documented macrofungus, and little is known about its chemical composition and biological potential. This study provides an integrated morphological, molecular, and chemical characterization of P. gallica collected from Constantine, Algeria, along with phylogenetic analysis and an in silico evaluation of its antioxidant and anti-inflammatory activities. Macroscopic observations revealed caps 3-8 cm in diameter, initially viscid, with adnate to slightly emarginate gills and rust-brown spore prints. Molecular analysis based on ITS rDNA confirmed the specimens as P. gallica, forming a well-supported clade with reference strains and clearly separated from closely related species. Chemical profiling showed a predominance of esters and terpenes, with 2,2,4-trimethylpentanediol-1,3-diisobutyrate (31.7%), 3-methylapopinene (19.2%), and 2,9-dimethyldecane (14.5%) as major components. The fatty acid profile was rich in unsaturated acids, particularly linoleic acid (44.8%) and oleic acid (33.1%), known for their antioxidant, anti-inflammatory, and antimicrobial properties. Molecular docking studies demonstrated strong binding interactions of these compounds with XO, MPO, 5-LOX, COX-2, and iNOS, suggesting their contribution to the bioactivity of P. gallica. These findings provide a solid foundation for future experimental studies and highlight the pharmacological potential of this macrofungus.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.